Overview / Abstract: |
Dr. Sahil Khanna and Dr. Kevin Garey use a case-based approach to walk participants through the selection of therapy for two patients with C. difficile infection. Discussion topics include risk factors, triaging severity of infection, and guideline-recommended therapies. Clinical decision points throughout the activity allow learners to test their skills in managing patients with C. difficile, identify risk factors, and treat with available antimicrobial therapies. |
Expiration |
Aug 31, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Pharmacy CPE, Physician CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
.75 |
Accreditation |
ACCME, ACPE |
Presenters / Authors / Faculty |
Sahil Khanna, MBBS, MS Kevin W. Garey, PharmD, MS |
Sponsors / Supporters / Grant Providers |
Sponsored by the Academy for Continued Healthcare Learning (ACHL). Supported by educational grants from Ferring Pharmaceuticals Inc., and Merck & Company. |
Keywords / Search Terms |
ACHL C. difficile, CME/CE/CPE, ID-week, Dr. Feuerstadt, Dr. Khanna, Dr. Garey, microbiome, gut microbiota, role of the gut, recurrent, infections, infectious disease, physician, pharmacists, , microbiota restoration therapy, FMT, fecal microbiota transplant, intestinal microbiota transplant, fecal microbiota for transplantation, bacterial infections, gram-negative, clinical cases, fidaxomicin, vancomycin Free CE CME |